Avricore Health Refocuses Strategy to Unlock Growth Potential
VANCOUVER, British Columbia, Nov. 14, 2024 (GLOBE NEWSWIRE) — Avricore Health Inc. (TSX-V: AVCR) (“Avricore” or the “Company”), a leader […]
BIO-key Reports Q3’24 Revenue Rose 18% to $2.1M, Reduced Q3’24 Net Loss, and Improved Cash Position; Hosts Investor Call Tomorrow, Fri. Nov. 15th, 10am ET
HOLMDEL, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) — BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer […]
Beam Global to Release Q3 2024 Operating Results Conference Call Scheduled for November 15, 2024 at 4:30 p.m. ET
SAN DIEGO, Nov. 14, 2024 (GLOBE NEWSWIRE) — Beam Global, (Nasdaq: BEEM), (the “Company”), a leading provider of innovative and […]
Banzai Reports Third Quarter 2024 Financial Results; Annualized Adjusted Net Loss Improvement of $12.2 Million
Q3 2024 Annual Recurring Revenue Increased by 31% Annualized to $4.4 Million, a 7% Sequential Increase from Q2 2024 Q3 […]
DIH Announces Second Quarter 2025 Financial Results and Restates June 30, 2024 Form 10-Q
NORWELL, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) — DIH Holding US, Inc. (“DIH”)(NASDAQ:DHAI), a global provider of advanced robotic devices […]
Firefly Neuroscience Reports Third Quarter 2024 Results and Provides Stockholder Update
Company successfully listed on Nasdaq under the symbol “AIFF” Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and […]
Adams Diversified Equity Fund Declares Year-End Distribution
BALTIMORE, Nov. 14, 2024 (GLOBE NEWSWIRE) — Adams Diversified Equity Fund, Inc. (NYSE: ADX) declared today a year-end distribution of […]
TSX News -
Avicanna Reports Q3 2024
9-month revenue of $18.8 million, representing a 75% increase from 2023. Consolidated Gross Margins of 57%, during Q3 2024. TORONTO, […]
